Literature DB >> 14962390

The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague.

Urszula Derewenda1, Agnieszka Mateja, Yancho Devedjiev, Karen M Routzahn, Artem G Evdokimov, Zygmunt S Derewenda, David S Waugh.   

Abstract

The LcrV protein (V-antigen) is a multifunctional virulence factor in Yersinia pestis, the causative agent of plague. LcrV regulates the translocation of cytotoxic effector proteins from the bacterium into the cytosol of mammalian cells via a type III secretion system, possesses antihost activities of its own, and is also an active and passive mediator of resistance to disease. Although a crystal structure of this protein has been actively sought for better understanding of its role in pathogenesis, the wild-type LcrV was found to be recalcitrant to crystallization. We employed a surface entropy reduction mutagenesis strategy to obtain crystals of LcrV that diffract to 2.2 A and determined its structure. The refined model reveals a dumbbell-like molecule with a novel fold that includes an unexpected coiled-coil motif, and provides a detailed three-dimensional roadmap for exploring structure-function relationships in this essential virulence determinant.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962390     DOI: 10.1016/j.str.2004.01.010

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  72 in total

Review 1.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

Review 2.  The blueprint of the type-3 injectisome.

Authors:  Agata Kosarewicz; Lisa Königsmaier; Thomas C Marlovits
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-04-19       Impact factor: 6.237

Review 3.  Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.

Authors:  Daniela Büttner
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

4.  Application of protein engineering to enhance crystallizability and improve crystal properties.

Authors:  Zygmunt S Derewenda
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-04-21

5.  Characterization of the interaction between the Salmonella type III secretion system tip protein SipD and the needle protein PrgI by paramagnetic relaxation enhancement.

Authors:  Thenmalarchelvi Rathinavelan; Chun Tang; Roberto N De Guzman
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

6.  The substrate specificity of Metarhizium anisopliae and Bos taurus carboxypeptidases A: insights into their use as tools for the removal of affinity tags.

Authors:  Brian P Austin; József Tözsér; Péter Bagossi; Joseph E Tropea; David S Waugh
Journal:  Protein Expr Purif       Date:  2010-11-10       Impact factor: 1.650

7.  The crystal structures of the Salmonella type III secretion system tip protein SipD in complex with deoxycholate and chenodeoxycholate.

Authors:  Srirupa Chatterjee; Dalian Zhong; Bryce A Nordhues; Kevin P Battaile; Scott Lovell; Roberto N De Guzman
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

8.  Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.

Authors:  Teiji Sawa; Emi Ito; Vinh Huu Nguyen; Matthew Haight
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Amino acid residues 196-225 of LcrV represent a plague protective epitope.

Authors:  Lauriane E Quenee; Bryan J Berube; Joshua Segal; Derek Elli; Nancy A Ciletti; Deborah Anderson; Olaf Schneewind
Journal:  Vaccine       Date:  2009-12-10       Impact factor: 3.641

10.  LcrV mutants that abolish Yersinia type III injectisome function.

Authors:  Katherine Given Ligtenberg; Nathan C Miller; Anthony Mitchell; Gregory V Plano; Olaf Schneewind
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.